At least one NFL owner has confidence in new Dallas Cowboys head coach Brian Schottenheimer. Kansas City Chiefs owner Clark Hunt has expressed strong support for the Cowboys' decision to hire ...

Bill Belichick’s youngest son, Brian, is expected to join the UNC defensive staff as the safeties coach this upcoming college football season, according to Matt Zenitz of CBS Sports and 247Sports.

Actor and comedian Brian Murphy has died aged 92. He was known for his role in the 1970s sitcoms Man About The House and George And Mildred. News of his passing was shared by his wife Hi-de-Hi!

Sit-com legend Brian Murphy has died, aged 92. Brian Murphy was best known for his role as George Roper in the sitcoms Man About the House (1973–1976) and its spin-off George and Mildred (1976 ...

Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs. Novo Nordisk said its fourth ...

Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said on Wednesday its net profit jumped 21 per cent in 2024 to 100 billion Danish ...

While Novo’s type 2 diabetes GLP-1 Ozempic has largely stolen the show in recent years, obesity med Wegovy—which utilizes the same molecule semaglutide at higher doses than Ozempic ...

Novo Nordisk A/S Bagsværd, Denmark, 5 February 2025 – Novo Nordisk A/S has filed its Annual Report 2024 on Form 20-F for the financial year 2024 with the US Securities and Exchange Commission ...

LONDON/COPENHAGEN, Feb 5 (Reuters) - Novo Nordisk emissions grew 23% in 2024, the company said on Wednesday, and will keep rising through the end of the decade as it boosts production of ...

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks Consensus Estimate for quarterly revenues in the to-be-reported quarter is ...

Novo Nordisk reported strong data for its next-gen anti-obesity medicine. The Danish company has an excellent weight loss drug pipeline. But it's also diversifying its lineup and offering other perks.

Novo Nordisk shares rose after the drugmaker reported strong sales growth for its blockbuster obesity and diabetes drugs and issued a forecast for full-year 2025 results that topped analysts ...